ALVOW
Alvotech WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.21
52W High
$2.74
52W Low
$0.15
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-14.40%
Forward P/E
—
PEG Ratio
—
About Alvotech Warrant
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
Fundamentals
| Revenue (TTM) | $562.04M |
| Gross Profit (TTM) | $345.85M |
| EBITDA | $104.24M |
| Operating Margin | 9.13% |
| Return on Equity | 0.00% |
| Return on Assets | 3.84% |
| Revenue/Share (TTM) | $1.92 |
| Book Value | $-0.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -99.00% |
| Quarterly Revenue Growth (YoY) | -20.20% |
| Shares Outstanding | 0 |
| Float | $113.59M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
184.83%
HV 20-Day
218.59%
HV 30-Day
201.65%
HV 60-Day
200.41%
HV Rank
—
Volatility is currently contracting
Data last updated: 6/13/2026